HALOZYME PROVIDES UPDATE ON LICENSEE CO-FORMULATION PATENT HEARING IN EUROPE

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/3/2026

1. PANW
2. GTLB
3. MDB
4. DELL
5. SNOW
6. AVGO
7. HPE
8. RARE
9. GOOGL
10. VRTS

Go back to HALOZYME PROVIDES UPDATE ON LICENSEE CO-FORMULATION PATENT HEARING IN EUROPE
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 109.66 --0 (-0%)
Previous Close $109.66    52 Week High $18.39 
Open $109.66    52 Week Low $6.96 
Day High $109.66    P/E N/A 
Day Low $109.66    EPS $-0.58 
Volume 6